Literature DB >> 16187184

Steroid-responsive (autoimmune?) sclerosing cholangitis.

Jasjeet S Sekhon1, Raymond T Chung, Mark Epstein, Marshall M Kaplan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187184     DOI: 10.1007/s10620-005-2948-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  16 in total

1.  PERICHOLANGITIS AND ULCERATIVE COLITIS. II. CLINICAL ASPECTS.

Authors:  S P MISTILIS; A P SKYRING; S J GOULSTON
Journal:  Ann Intern Med       Date:  1965-07       Impact factor: 25.391

2.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

3.  Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.

Authors:  C Schramm; P Schirmacher; I Helmreich-Becker; G Gerken; K H zum Büschenfelde; A W Lohse
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

4.  A revised natural history model for primary sclerosing cholangitis.

Authors:  W R Kim; T M Therneau; R H Wiesner; J J Poterucha; J T Benson; M Malinchoc; N F LaRusso; K D Lindor; E R Dickson
Journal:  Mayo Clin Proc       Date:  2000-07       Impact factor: 7.616

5.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 6.  Primary sclerosing cholangitis.

Authors:  Y M Lee; M M Kaplan
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

7.  Treatment of primary sclerosing cholangitis with oral methotrexate.

Authors:  T A Knox; M M Kaplan
Journal:  Am J Gastroenterol       Date:  1991-05       Impact factor: 10.864

8.  Primary sclerosing cholangitis: refinement and validation of survival models.

Authors:  E R Dickson; P A Murtaugh; R H Wiesner; P M Grambsch; T R Fleming; J Ludwig; N F LaRusso; M Malinchoc; R W Chapman; M M Kaplan
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

9.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

10.  Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic response.

Authors:  M M Kaplan; S Arora; S H Pincus
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

View more
  2 in total

Review 1.  Primary sclerosing cholangitis--what is the difference between east and west?

Authors:  Ali Shorbagi; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  Secondary Sclerosing Cholangitis and Hodgkin's Lymphoma.

Authors:  Seyed Hassan Abedi; Maryam Ghassami; Mahsa Molaei; Zhaleh Mohsenifar; Amir Houshang Mohammad Alizadeh
Journal:  Clin Med Insights Case Rep       Date:  2015-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.